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irrespective of whether FFR or CFVR is ischemic. This underscores the requirement of
both flow and pressure assessment for optimal risk stratification.
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Background: Non-invasive fractional flow reserve (FFR) derived from typically
acquired coronary computed tomographic (CT) angiography (FFRCT) is a novel method
that employs computational fluid dynamics to diagnose coronary lesions that cause
ischemia. To date, the diagnostic performance of FFRCT versus CT stenosis to effectively
diagnose ischemia in vessels with stenosis of intermediate severity (30-70% luminal
diameter stenosis) has been inadequately studied.
Methods: Amongst 407 vessels from 252 patients at 17 centers in 4 countries who
underwent CT, FFRCT, invasive coronary angiography and invasive FFR, we identified
150 vessels of intermediate stenosis severity by CT. CT stenosis, FFRCT, and invasive
FFR were interpreted in blinded fashion by independent core laboratories. FFRCT and
FFR 0.80 were considered ischemic, while CT stenosis 50% were considered
obstructive. Diagnostic performance of CT stenosis alone versus FFRCT alone were
evaluated for sensitivity, specificity, positive predictive value (PPV), and negative
predictive value (NPV); as well as employing a decision rule combining FFRCT and CT
stenosis wherein maximal per-patient CT stenosis 30% was considered negative for
ischemia and subtotal or total occlusions were considered positive for ischemia. Area
under the receiver operating characteristics curve for FFRCT and CT stenosis were
compared for discrimination.
Results: For lesions of intermediate stenosis severity, FFRCT demonstrated a sensitivity,
specificity, PPV and NPV of 74%, 66%, 40%, and 89%; while CT stenosis demonstrated
a sensitivity, specificity, PPV and NPV of 34%, 72%, 27%, 78%. When applying the
decision rule, the combination of FFRCT and CT stenosis resulted in a sensitivity,
specificity, PPV and NPV of 74%, 67%, 39% and 90%. The AUC of FFRCT for
discrimination of ischemia in stenoses of intermediate severity was higher than CT
stenosis (0.80 vs. 0.55, p0.0001), with no added improvement when CT stenosis was
added to FFRCT (0.81 vs. 0.80).
Conclusions: Compared to CT, FFRCT possesses higher diagnostic performance for
lesions of intermediate severity, with a 2X increase in sensitivity and superior NPV,
suggesting its role to identify lesions that are not ischemic.
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Background: Previous IVUS studies examining correlates of drug-eluting stent (DES)
thrombosis were retrospective and in small patient cohorts.
Methods: ADAPT-DES was a prospective, multicenter, real-world registry of 8,575
consecutive pts at 11 international centers treated with percutaneous coronary intervention
(PCI) using DES designed to determine the frequency, timing, and correlates (clinical,
angiographic and platelet reactivity) of early and late DES thrombosis. A pre-specified
IVUS substudy enrolled 2,438 IVUS-guided PCI lesions in 2,064 pts; baseline grayscale
volumetric IVUS analysis was prospectively done at an independent core laboratory, and
1-year follow-up was completed.
Results: Average pt age was 64.0 years and 75.4% were male. Stent thrombosis (ST)
occurred in 10 pts (0.5%); 7 definite and 3 probable (median 14.5 days). ST lesions had
more attenuated plaque – a grayscale IVUS marker of a large necrotic core or a thin-cap
fibroatheroma - along with greater tissue protrusion through the stent into the lumen,
reference plaque burden and edge dissections (Table). Minimum lumen area, stent
expansion, and acute malapposition were similar in ST vs no ST.
ST (n10) No ST (n2428) p value
Stent length, mm 32.6 [22.7, 55.0] 23.8 [17.1, 33.7] 0.16
Minimum lumen area
(MLA), mm2
5.4 [4.4, 7.5] 5.8 [4.5, 7.6] 0.82
Stent expansion (MSA/
reference lumen area), %
69.9 [58.2, 86.7] 73.1 [62.1, 84.4] 0.68
Post-stent abluminal plaque
burden, %
58.6 [50.9, 61.5] 51.7 [47.1, 56.2] 0.09
Proximal reference plaque
burden, %
57.8 [48.2, 70.9] 45.4 [38.4, 53.0] 0.02
Lesions with intra-stent
tissue protrusion, %
50% (5/10) 34.3% (834/2428) 0.33
Maximum tissue protrusion
area, mm2
1.9 [1.3, 2.1] 0.7 [0.5, 1.2] 0.02
Lesions with attenuated
plaque behind stent, %
80% (8/10) 62.5% (1517/2428) 0.34
Maximum attenuated
plaque arc, °
118 [83, 155] 80 [50,110] 0.04
Total attenuated plaque
length, mm
17.7 [5.6, 23.1] 5.8 [2.9, 11.1] 0.01
Proximal reference
attenuated plaque, %
60% (6/10) 26.6% (586/2200) 0.03
Distal edge dissection
(deeper than media), %
25% (2/8) 2.5% (58/2360) 0.02
Stent malapposition, % 20% (2/10) 15.9% (387/2428) 0.67
Conclusions: In the present analysis from the largest prospective IVUS study to date, the
presence of attenuated plaque, tissue protrusion, reference segment plaque burden and
edge dissections were significant predictors of ST, whereas underexpansion and malap-
position were not. This highlights the complex relationship between underlying lesion
morphology, PCI results and outcomes in pts treated with DES.
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Background: Whether IVUS guidance reduces stent thrombosis and improves clinical
outcomes after DES is unknown, with only small observational studies and no random-
ized trials having been reported.
Methods: ADAPT-DES was a prospective, multicenter, real-world registry of 8,576
consecutive pts at 11 international centers undergoing percutaneous coronary intervention
(PCI) with DES designed to determine the frequency, timing, and correlates (clinical,
angiographic and platelet reactivity) of early and late stent thrombosis. During the index
procedure, IVUS was used in 3,343 (39.0%) of cases and 1-year follow-up was
completed.
Results: Average pt age was 64.0 years and 74.1% were male. Patients in the IVUS
group were more likely to have ACS and high platelet reactivity to thienopyridine
(PRU208), and were treated with longer and larger stents, and more everolimus-eluting
stents. Within 1 year, definite/probable stent thrombosis (ST) occurred in 17 (0.52%) pts
in IVUS group vs in 53 (1.04%) pts in non-IVUS group (HR [95%CI] 0.37[0.20, 0.69],
p0.0016) (Table). In a propensity adjusted model to account for the predictors of IVUS
use, IVUS guidance was independently associated with a reduced 1-year rate of ST (HR
[95%CI]  0.37 [0.20, 0.68], p0.0014). All-cause death or MI also occurred signifi-
cantly less frequently in the IVUS group (Table) due to fewer cardiac deaths and non
peri-procedural MIs.
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Any ST within 1 year 0.52% 1.04% 0.01
- Acute ( 24 hours) 0.06% 0.04% 0.66
- Subacute (1-30 days) 0.27% 0.56% 0.05
- Late (31 days – 1 year) 0.25% 0.48% 0.1
All-cause death/MI within 1 year 3.96% 5.35% 0.004
Cardiac death within 1 year 0.84% 1.17% 0.1384
Peri-procedural MI 1.26% 1.53% 0.3
Non peri-procedural MI within 1 year 1.23% 2.17% 0.002
Conclusions: These data, drawn from the largest prospective registry of IVUS use to
date, suggests that IVUS guidance during DES PCI may result in less ST, non
peri-procedural MIs and cardiac mortality during 1 year follow-up.
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Background: High wall shear stress (WSS) and large plaque burden have each been
associated with development of coronary plaque vulnerability. We hypothesized that high
WSS, large plaque burden, and plaque phenotype have incremental value in prediction of
increased plaque vulnerability.
Methods: Twenty patients with non-obstructive CAD, treated with 80 mg/day atorva-
statin, underwent baseline and 6-month follow-up virtual histology-intravascular ultra-
sound (VH-IVUS), Doppler velocity, and computational fluid dynamics modeling for
calculation of WSS. In each IVUS frame (n2,249), plaque composition was classified
as necrotic core (NC), dense calcium (DC), fibro-fatty (FF), and fibrous (FI) and plaque
phenotype as pathological intimal thickening (PIT), fibrotic plaque, and fibroatheroma.
Expansive remodeling was defined as change in ()EEM area/plaque area1 and high
WSS as 25 dynes/cm2. Increased plaque vulnerability was considered as 1)increase in
NC, 2)decrease in FI or FF, 3)expansive remodeling.
Results: Among 3 phenotypes, PIT had the greatest increase in NC area (p0.06). At
follow-up, compared to segments with baseline high WSS or plaque burden60% or PIT
alone, coronary segments with a combination of high WSS, plaque burden 60%, and
PIT were associated with greater increase in NC area (p0.002), greater decrease in FF
(p0.004) and FI areas (p0.0001), and higher frequency of expansive remodeling
(p0.019).
Conclusions: In patients with CAD treated with statins, combination of high WSS,
plaque burden 60%, and PIT has an incremental value in predicting increased plaque
vulnerability at follow-up.
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Background: Autopsy studies suggest most ST-segment elevation myocardial infarc-
tions (STEMI) are caused by a ruptured lipid core plaque (LCP), yet this has not been
demonstrated in vivo. A novel combined near-infrared spectroscopy (NIRS) and intra-
vascular ultrasound (IVUS) catheter can now accurately detect LCP in pts.
Methods: We performed NIRS-IVUS in the culprit vessel of 18 consecutive STEMI pts
(age 5912; 83% male). To minimize alteration of the culprit plaque, NIRS-IVUS was
performed after establishment of TIMI 3 flow by a guidewire, small balloon or aspiration,
but prior to stent placement. LCP was quantitated as the lipid-core burden index (LCBI)
over a 10mm vessel segment, a measure of the fraction of NIRS measurements indicating
lipid. NIRS in STEMI pts was compared to findings in 329 stable coronary pts without MI
(age 6410; 79% male) and to autopsy specimens from 57 pts (age 6510; 64% male)
without histologic LCP.
Results: NIRS identified large, often circumferential LCP at the culprit site in 17 of 18
STEMI pts (94.4%; Figure). The LCBI was 372213 within the STEMI culprit vs
55100 in 4325 segments in stable coronary pts (p0.001) and vs 2752 in 446 autopsy
specimens without histologic LCPs (p0.001; 13-fold lower than STEMI culprits).
Conclusions: A NIRS signature of a large, often circumferential LCP was significantly
more frequent at STEMI culprits than in comparable regions in stable pts and in autopsy
specimens without LCPs. A prospective study is indicated to determine if such plaques
detected by NIRS prior to rupture place pts at risk for future acute coronary events and
cardiac death.
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